Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017
出版年份 2018 全文链接
标题
Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017
作者
关键词
-
出版物
DRUG SAFETY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-12-10
DOI
10.1007/s40264-018-0769-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside‐1000 (Monofer ® ) versus ferric carboxy‐maltose (Ferinject ® ). A single center, cohort study
- (2018) Midas B. Mulder et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The available intravenous iron formulations: History, efficacy, and toxicology
- (2017) Michael Auerbach et al. Hemodialysis International
- Modern iron replacement therapy: clinical and pathophysiological insights
- (2017) Domenico Girelli et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease
- (2016) Jehan Bahrainwala et al. SEMINARS IN NEPHROLOGY
- Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose
- (2015) Susann Neiser et al. BIOMETALS
- Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products
- (2015) Cunlin Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress
- (2013) Taija S. Koskenkorva-Frank et al. FREE RADICAL BIOLOGY AND MEDICINE
- Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America
- (2011) George Bailie et al. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
- Essential but toxic: Controlling the flux of iron in the body
- (2011) Gregory J Anderson et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The Case-Population Study Design
- (2011) Hélène Théophile et al. DRUG SAFETY
- A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
- (2011) Markus R. Jahn et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study
- (2011) Guillaume Moulis et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Intravenous iron: From anathema to standard of care
- (2008) Michael Auerbach et al. AMERICAN JOURNAL OF HEMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started